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While our understanding of cystic ﬁbrosis genetics has expanded in recent decades, the genetics and
clinical manifestations of the disease remains highly heterogeneous. Diagnosis of CF in non-classical
mutations remains a clinical challenge. We describe the clinical presentation of two patients with
chronic cough found to have normal sweat chlorides. We discuss the subsequent evaluation that lead to
the diagnosis of two rare CF mutations. We brieﬂy discuss the use of the expanded 106-panel of CF
mutations (homozygous 3849 þ 10 kb C > T), and the role of whole CFTR gene sequencing (heterozygous
c.2752-26 A > G/5T).
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cystic ﬁbrosis (CF) is a multisystem life-threatening genetic
disorder of Caucasian populations with an estimated incidence of 1
in 2500 live births. While CF survival has improved in recent de-
cades, life expectancy of CF patients remains just 40.7 years [1].
Early detection has been shown to improve outcomes, allowing
clinicians to better manage cystic ﬁbrosis prior to development of
irreversible respiratory complications as well as to optimize
nutrition, particularly during childhood and adolescence [2]. In
recent years, the detection of cystic ﬁbrosis has improved sub-
stantially with the widespread introduction of infant CF screening
coupled with improved understanding of CF genetics.
Despite improvements in our understanding of CF genetics,
diagnosis of CF in nonclassical mutations remains a clinical chal-
lenge. Adult patients may be more likely to present with nonclas-
sical mutations not detected on conventional CF screens [3,4], often
with a phenotype distinct from classical CF. We describe the ge-
netics and phenotype of two cases of rare CF mutations, one
diagnosed through an expanded 106-panel of CFmutations and one
through whole CFTR gene sequencing.Critical Care Medicine, Mayo
A.
av).
Ltd. This is an open access article u2. Case presentation
2.1. Case 1: homozygous 3849 þ 10KbC > T mutation in a 19-year-
old male
A 19-year-old Caucasian male was evaluated for chronic cough,
recurrent bronchitis, recurrent sinus infections and pneumonias
since age 9. He denied gastrointestinal symptoms and had no ex-
posures. He has a past surgical history of bilateral inguinal repair.
He had normal pulmonary function testing (PFT) and negative
cystic ﬁbrosis work up including normal sweat chloride test in the
past. His ethnic background was Ashkenazi. Family history was
signiﬁcant for paternal ﬁrst cousin with CF. He had recently
recovered from an acute exacerbation of bronchiectasis requiring
anti-infectives for Mycobacterium abscessus and Aspergillus. He
appeared malnourished (BMI 16.5 kg/m2) but had an otherwise
normal physical examination. He does not have congenital absence
of vas deference.
Laboratory studies showed a normal CBC and sweat chloride
(<30 mmol/L) [5]. Exhaled oral nitric oxide was normal and nasal
nitric oxide level excluded ciliary dyskinesia [6]. He had severe
extensive bilateral central cylindrical bronchiectasis on CT, micro-
nodularity, and patchy air space consolidations. Sinus CT showed
pansinusitis. Comprehensive immunodeﬁciency evaluation was
unrevealing. The 23-panel ACMG panel for CF mutations was
negative. His overall clinical presentation remained suspicious for
CF. A 106-mutation multiplex PCR assay (Sequenom MassArray,
University of Arizona Genetics Core) revealed two copies ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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aggressive airway clearance maintenance therapy with nebulized
albuterol and 7% hypertonic saline. His respiratory symptoms had
resolved and he was able to gain weight. At last follow up, his
weight is now in normal range and he is able to cycle over 10 miles
daily.2.2. Case 2: trans c.2752-26 A > G and intron 8 polyT 5T/7T
mutation in a 21-year-old male
A 21-year-old Caucasian male was evaluated for chronic cough,
nasal congestion and postnasal drip present for 3-years. His ethnic
background was Ashkenazi and he had no family history of CF. He
was well nourished (BMI 23.5 kg/m2) and had a normal physical
examination. There was some improvement in chronic cough after
treatment for rhinitis and excessive posterior rhinorrhea. Pulmo-
nary function testing was within normal limits: FEV1: 4.70 L (105%
predicted), FVC: 5.20 L (100% predicted), FEF25-75: 90.6%. He also
had normal sweat chloride levels (<30 mmol/L), chest X-ray and CT
of the sinuses. CT of the chest showed mild bronchial wall thick-
ening only, and no evidence of bronchiectasis. He developed
chronic diarrhea prompting gastrointestinal evaluation. Celiac
testing, upper endoscopy, small bowel biopsy and GI functional
imaging were all normal. Stool examination for ova and parasites
were negative. A 72-h fat collection study conﬁrmed steatorrhea
(13 g of fat/24 h). Fecal elastase was normal at 498.6 mg elastase/
gram stool. A 106-multiplex PCR assay (Sequenom MassArray,
University of Arizona Genetics Core) was negative for cystic ﬁbrosis.
Due to continued clinical suspicion for cystic ﬁbrosis, full CFTR gene
sequencing analysis was performed. He had two mutations usuallyFig. 1. Algorithm for the diagnosis of suspected cystic ﬁbrosis in adults presenting with s
Medical Genetics, DNA: deoxyribonucleic acid.considered benign: a c.2752-26 A > G mutation on intron 14a and
an intron 8 polyT allele 5T/7T of the CFTR gene. Parental gene
analysis revealed that the mutations were in trans position. His
diarrhea responded to pancreatic enzyme supplementation.3. Discussion
While our understanding of cystic ﬁbrosis genetics has
expanded in recent decades, the genetics and clinical manifesta-
tions of the disease remains highly heterogeneous. Most patients
not identiﬁed at infancy undergo screening after development of
characteristic pulmonary or gastrointestinal symptoms. Most cur-
rent centers ﬁrst screen patients with sweat chloride testing fol-
lowed by genetic screening for the American College of Medical
Genetics (ACMG) panel of the 23 most common CF-causing muta-
tions. This panel will detect 90% of mutations in Caucasian pop-
ulations, 97% of mutations in Ashkenazi Jews but just 69% of
mutations in Hispanic populations [7]. Consequently different re-
gions modify their testing panels to suit local population
demographics.
This report describes the presentation and the stepwise genetic
workup of two exceedingly rare CF mutations. Both cases meet
diagnostic criteria for CF by having clinical CF-like symptoms and
two abnormal CF genes in trans position [8,9]. Both had normal
sweat chlorides (<30 mmol/l). The ﬁrst patient was homozygous
for 3849 þ 10KbC > T splicing mutation. The heterozygous
3849 þ 10 kb C > T mutation generally has a mild clinical
phenotype [10]. It occurs most commonly with theD508 deletion
[11e13]. To our knowledge, this is just the seventh case report of
homozygous 3849 þ 10 kb C > T mutation [14e17]. The patientymptoms suggestive of cystic ﬁbrosis. CF: cystic ﬁbrosis, ACMG: American College of
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gastrointestinal symptoms or nutritional deﬁciencies, but was
malnourished with an initial BMI of 16.6. This is probably due to
recurrent acute illness, and BMI increased to 18.6 with nutritional
counseling. The patient also had signiﬁcant sinus disease at a young
age, and ultimately had severe areas of bronchiectasis and coloni-
zation with resistant organisms (Mycobacterium Avium Complex,
Burkoldheria Cepacia, Aspergillus sp. and Pseudomonas Aeruginosa).
Even though our patient had severe airway damage at the time of
evaluation, his spirometry was normal.
The patient with trans c.2752-26 A > G splicing defect and 5T
allele had persistent cough and sinus symptoms for many years,
with relatively minimal structural lung disease. This is the ﬁrst
reported case of cystic ﬁbrosis with heterozygous c.2752-26 A > G/
5T mutation and second case of the c.2752-26 A > G mutation
causing clinical disease. The original description of c.2752-26 A > G
splicing defect was in a toddler with failure to thrive [18]. Although
the second CF allele in the child was not tested, sweat tests were
borderline and there was no pulmonary disease or pancreatic
insufﬁciency at time of diagnosis. This case in particular highlights
the importance of stepwise genetic testing, starting with the 23-
mutation panel, followed by the 106 multiplex PCR panel and,
ﬁnally, full CF gene sequencing.
In recent years, improvements in diagnostic testing have
allowed identiﬁcation of milder phenotypes, often with only
partially reduced CFTR function [19]. Algorithms published have
based diagnostic workup on sweat chloride levels [8]. Sweat chlo-
ride can be normal in individuals with CF [20]. These patients with
normal sweat chloride levels may not have mutations commonly
tested in the 23-mutation ACMG panel. Consequently, this may lead
to misdiagnosis or delayed diagnosis, the possibility of developing
disease complications before eventual diagnosis, and lack of time-
appropriate genetic counseling. The 106-gene multiplex PCR may
be an intermediary step before full gene sequencing especially in
young adults with history suspicious for CF. Full CFTR genetic
sequencing is best reserved as the ﬁnal genetic test for the presence
of a mutation in all 27 exons of the CFTR gene. Occasionally, it can
be helpful to genotype a patients' parents to determine whether
mutations are in cis (same chromosome) or in trans position. An
algorithm for the stepwise diagnosis of CF in adult patients pre-
senting with symptoms suggestive of possible CF is outlined in
Fig. 1.4. Conclusion
Mutations in 3849 þ 10KbC > T and c.2752-26 A > G are rare,
and associated with a milder phenotype of cystic ﬁbrosis.
3849 þ 10KbC > T mutation was only detected with an expanded
106-mutation analysis, while detection of c.2752-26 A > G required
whole CFTR gene sequencing. Our report highlights the importance
of further genetic testing in patients where clinical suspicion of CF
remains despite initially normal CF testing.Conﬂict of interest
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